Pharma partnering in PM space

PM is all about aligning the therapy and the diagnostic, both in development and commercialization. As the pharma development pipelines are increasingly dependent on a biomarker we are witnessing an increasing trend in PM partnering deals.

The following data from Diaceutics illustrate the partnering activity in the PM space.